Skip to search.
 Dow Down 0.60% Nasdaq Down 0.07%

Bio-Rad Laboratories, Inc. (BIO)

-NYSE

101.39 Down 0.63(0.62%) May 25, 4:02PM EDT|After Hours: 101.39 0.00 (0.00%) May 25, 4:28PM EDT

ProfileGet Profile for:
Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules, CA 94547
United States - Map
Phone: 510-724-7000
Fax: 510-741-5815
Website: http://www.bio-rad.com

Details 
Index Membership:N/A
Sector:Technology
Industry:Scientific & Technical Instruments
Full Time Employees:7,030

Business Summary 

Bio-Rad Laboratories, Inc. engages in the manufacture and distribution of life science research and clinical diagnostic products worldwide. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. This segment serves various customers, including universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for the healthcare market. This segment sells its products to reference laboratories, hospital laboratories, screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Bio-Rad Laboratories, Inc.

Corporate Governance 
Bio-Rad Laboratories, Inc.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (High Concern), Compensation (Low Concern), Shareholder Rights (Medium Concern).
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Norman D. Schwartz , 62
Chief Exec. Officer, Pres and Director
940.00K211.00K
Ms. Christine A. Tsingos , 53
Chief Financial Officer and VP
486.00K321.00K
Mr. John Goetz , 62
VP and Group Mang. of Clinical Diagnostics Group
647.00K737.00K
Mr. Bradford J. Crutchfield , 49
VP and Group Mang. of Life Science Group
511.00K583.00K
Mr. Sanford S. Wadler , 65
VP, Sec. and Gen. Counsel
N/AN/A
Amounts are as of Dec 30, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders